Amgen CEO says he’s ‘confident’ in deal with Horizon despite FTC lawsuit

A day after federal antitrust authorities sued to stop Amgen’s $28 billion takeover of Horizon Therapeutics, Amgen’s CEO said he still expects the deal to close. “We remain excited about the prospect of this combination,” Amgen CEO Robert Bradway said at an event hosted by the Financial Times on Wednesday…